Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage
- PMID: 200907
- PMCID: PMC431906
- DOI: 10.1073/pnas.74.10.4200
Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage
Abstract
Human leukocyte interferon (HuLeIF) preparations contain distinct molecular forms of interferon exhibiting significant heterogeneties in sizes when analyzed by electrophoresis in sodium dodecyl sulfate (NaDodSO(4))/polyacrylamide gels, migrating in two broad bands of activity with peaks at about 21,000 and 15,000 daltons. HuLeIFs exhibit extensive charge heterogeneities when analyzed by isoelectric focusing, resolving into several major peaks of approximately equal activity distributed from pH 5.7 to 7.0. When HuLeIF preparations are treated with 0.01 M sodium periodate buffer, pH 4.5, at 4 degrees , both the size and charge heterogeneities rapidly disappear: periodate-treated HuLeIF migrates as a single, narrow band at 15,000 daltons in NaDodSO(4)/polyacrylamide gels and focuses as a single, narrow band at pH 5.7. Quantitative considerations suggest that either the larger, heterogeneously charged HuLeIFs are converted to the smaller, size- and charge-homogeneous interferon by extensive chemical deglycosylation, or, alternatively, the smaller, 15,000 dalton, pH 5.7 interferon is much more stable to periodate treatment than are the other interferon forms. However, the activity of each of the variously charged forms of HuLeIF isolated from focusing gels exhibited the same stability as the pH 5.7 component; similarly, the activity of each of the size-forms of HuLeIF isolated from NaDodSO(4)/polyacrylamide gels exhibited the same stability as the 15,000-dalton interferon.
Similar articles
-
Human leukocyte interferon: separation of biologically different species by modification of carbohydrate moieties.Arch Virol. 1980;63(2):133-42. doi: 10.1007/BF01320770. Arch Virol. 1980. PMID: 6243919
-
Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.Proc Natl Acad Sci U S A. 1978 Oct;75(10):4814-8. doi: 10.1073/pnas.75.10.4814. Proc Natl Acad Sci U S A. 1978. PMID: 217001 Free PMC article.
-
The complete purification of human leucocyte interferon.Scand J Immunol. 1980;11(5):489-502. doi: 10.1111/j.1365-3083.1980.tb00017.x. Scand J Immunol. 1980. PMID: 6155691
-
Spontaneous production of human interferon.Proc Natl Acad Sci U S A. 1980 Oct;77(10):5938-42. doi: 10.1073/pnas.77.10.5938. Proc Natl Acad Sci U S A. 1980. PMID: 6160588 Free PMC article.
-
Mechanisms of cross-species activity of mammalian interferons.Pharmacol Ther. 1979;7(2):245-52. doi: 10.1016/0163-7258(79)90031-7. Pharmacol Ther. 1979. PMID: 392554 Review. No abstract available.
Cited by
-
Human leukocyte interferon: separation of biologically different species by modification of carbohydrate moieties.Arch Virol. 1980;63(2):133-42. doi: 10.1007/BF01320770. Arch Virol. 1980. PMID: 6243919
-
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.J Virol. 2015 Aug;89(15):7506-20. doi: 10.1128/JVI.00013-15. Epub 2015 May 13. J Virol. 2015. PMID: 25972554 Free PMC article.
-
Glycosylation of human leukocyte interferon: effects of tunicamycin.Arch Virol. 1980;64(2):109-17. doi: 10.1007/BF01318014. Arch Virol. 1980. PMID: 6155895
-
Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.Proc Natl Acad Sci U S A. 1978 Oct;75(10):4814-8. doi: 10.1073/pnas.75.10.4814. Proc Natl Acad Sci U S A. 1978. PMID: 217001 Free PMC article.
-
Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.Biochem J. 1981 Mar 1;193(3):947-51. doi: 10.1042/bj1930947. Biochem J. 1981. PMID: 6171256 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources